Biogen Forecasts 2026 Revenue Decline, But Growth Prospects On The Horizon

Guidance Anticipates A Mid-Single-Digit Decrease

 
• By Mandy Jackson
  
Biogen has one big Phase III readout and three Phase II readouts on tap for 2026 (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business